Nasdaq · Healthcare

Journey Medical Corp (DERM)

As-reported financials and recent SEC filings for Journey Medical Corp, latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$61.2M

Net income

$-11.4M

Net margin

-18.7%

Diluted EPS

$-0.47

ROE

-35.9%

P/E (TTM)

—

Market cap

—

Debt / equity

0.8×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$61.2M	$55.1M	$59.7M	$71.0M	$63.1M
Gross profit	$40.3M	$34.3M	$36.8M	$40.2M	$31.1M
Operating income	$-8.2M	$-13.7M	$-2.1M	$-27.5M	$-34.9M
Net income	$-11.4M	$-14.7M	$-3.9M	$-29.6M	$-44.0M
Diluted EPS	$-0.47	$-0.72	$-0.21	$-1.69	$-4.32

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

42026-07-02

42026-07-02

42026-07-02

42026-06-29

42026-06-26

42026-06-26

42026-06-26

42026-06-26

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on DERM

Search Journey Medical Corp’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.